An alternative to saline irrigation, IrriMax® Corporation introduces IrriSept®, a FDA-cleared wound debridement and cleansing system containing chlorhexidine gluconate (CHG). The 0.05 percent CHG concentration in IrriSept has been shown effective in laboratory testing against a variety of bacteria and fungi, including Staph and methicillin-resistant Staphylococcus aureus (MRSA).1,2 The solution has passed FDA-required tests for cytotoxicity, skin irritation and immune (allergic) response.3
Instead of cleansing a wound with just normal saline, healthcare professionals can now apply IrriSept with CHG directly to surgical or deep traumatic wounds, burns, abrasions, lacerations, SSTIs including abscesses, delayed closures, dehiscence, pilonidal cysts or infected wounds. IrriSept is designed for use in operating rooms, wound care centers, Emergency Departments, burn units and other healthcare settings.
According to the company, the IrriSept delivery system goes like this:
Step 1: Debride and cleanse. Through bottle compression, the patented IrriSept system delivers 450mL of solution in less than 30 seconds to effectively loosen and remove wound debris and bacteria without harming underlying tissues.
Step 2: Rinse one minute later with IrriRinse®.
IrriSept is available for use in surgical and non-surgical environments. The surgical product – labeled IrriSept O.R. – includes a choice of three irrigation applicators: the original SplatterGuard® and the LT SplatterGuard®, designed specifically for abscess cleansing, that reduce healthcare workers’ exposure to biohazard aerosolized contamination, as well as the IrriProbe™ for deeper wound cleansing. The non-surgical product – labeled IrriSept – includes the same applicators with the exception of the O.R.-specific IrriProbe.
For more information, visit www.irrisept.com 
1 Laboratory Testing Records per USP <51>, Antimicrobial Effectiveness Testing, on file at IrriMax Corporation
2 Laboratory Testing Records, “Chlorhexidine Gluconate (CHG) Bacterial Study Report,” on file at IrriMax Corporation
3 Biocompatibility compliance tests completed per FDA’s Blue Book Memorandum G95-1 and ISO 10993-1, Biological Evaluation of Medical Devices, on file at IrriMax Corporation